Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.3)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2006, vol. 15, nr 6, November-December, p. 1047–1053

Publication type: review article

Language: English

The Influence of Obesity, Distribution of Fat Tissue and Leptin on Risk of Developing of Cardiovascular Disease in Women

Znaczenie otyłości, rozmieszczenia tkanki tłuszczowej i leptyny w występowaniu chorób układu sercowo−naczyniowego u kobiet

Andrzej Dubiński1,, Zygmunt Zdrojewicz2,

1 Regional Health Centre, Internal Ward of Regional Hospital, Kamienna Góra, Poland

2 Chair and Department of Endocrinology and Diabetology, Silesian Piasts University of Medicine, Wrocław, Poland

Abstract

The role of visceral fat and central obesity on metabolic syndrome and cardiovascular disease was well presented in literature. Comparatively, the role of abdominal subcutaneous fat, especially in women regardless of the degree of obesity, is not well known. In this study is shown the influence of the distribution of abdominal fat, obesity, hypertension and age on leptin concentration and the development of cardiovascular diseases. It is also presented, that the main product of abdominal subcutaneous fat−leptin is produced by female organisms and the concentration of leptin is much higher. This research may provide evidence, that hyperleptinemia and risk of developing of atherosclerosis, especially in postmenopausal women, are strictly connected and hyperleptinemia is of great importance. Key word: leptin, obesity, abdominal subcutaneous fat, hypertension.

Streszczenie

Wpływ trzewnej tkanki tłuszczowej i związanej z nią otyłości androidalnej na występowanie zespołu metabolicznego i chorób układu sercowo−naczyniowego przedstawiono w wielu opracowaniach naukowych. Mniej wiadomo o roli, jaką pełni podskórna tkanka tłuszczowa, zwłaszcza u kobiet i to niezależnie od stopnia otyłości. W pracy omówiono wpływ rozmieszczenia tkanki tłuszczowej, otyłości, nadciśnienia tętniczego oraz wieku na stężenie leptyny we krwi oraz występowanie chorób układu sercowo−naczyniowego u kobiet. Wskazano, iż podstawowy produkt podskórnej tkanki tłuszczowej – leptyna jest wytwarzany u kobiet w znacznie większych stężeniach. Przedstawione badania mogą świadczyć o istotnej roli hiperleptynemii w wystąpieniu i progresji miażdżycy u kobiet, zwłaszcza w okresie pomenopauzalnym.

Słowa kluczowe

leptyna, otyłość, tkanka tłuszczowa podskórna, nadciśnienie tętnicze

References (49)

  1. Lean ME: Obesity: burdens of illness and strategies for prevention or management. Drugs Today (Barc) 2000, 36, 773–784.
  2. Milewicz A, Jedrzejuk D, Lwow F, Bialynicka AS, Lopatynski J, Mardarowicz G, Zahorska−Markiewicz B: Prevalence of obesity in Poland. Obes Rev 2005, 6, 113–114.
  3. Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK: Obesity and incidence of cancer: a large cohort study of over 145000 adults in Austria. Br J Cancer 2005, 93, 1062–1067.
  4. Bonora E, Micciolo R, Ghiatas AA, Lancaster JL, Alyassin A, Muggeo M, DeFronzo RA: Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism 1995, 44,1617–1625.
  5. Wajchenberg BL, Giannella−Neto D, da Silva ME, Santos RF: Depot−specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002, 34, 616–621.
  6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486–2497.
  7. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287, 356–359.
  8. You T, Ryan AS, Nicklas BJ: The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004, 89, 5517–5522.
  9. Toth MJ, Tchernof A, Sites CK, Poehlman ET: Menopause−related changes in body fat distribution. Ann N Y Acad Sci 2000, 904, 502–506.
  10. Milewicz A, Tworowska U, Demissie M: Menopausal obesity−myth or fact? Climacteric 2001, 4, 273–283.
  11. Milewicz A, Bidzinska B, Mikulski E, Demissie M, Tworowska U: Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels. Gynecol Endocrinol 2000, 14, 196–203.
  12. You T, Yang R, Lyles MF, Gong D, Nicklas BJ: Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab 2005, 288, E741–E747.
  13. Coppack SW: Pro−inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001, 60, 349–356.
  14. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M: Interactions between leptin and the human sympathetic nervous system. Hypertension 2003, 41, 1072–1079.
  15. Hall JE, Brands MW, Hildebrandt DA, Kuo J, Fitzgerald S: Role of sympathetic nervous system and neuropeptides in obesity hypertension. Braz J Med Biol Res 2000, 33, 605–618.
  16. Kelley DE, Thaete F, Troost F, Huwe T, Goodpaste BH: Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000, 278, E941–E948.
  17. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Hakkinen AM, Fredriksson J, Yki−Jarvinen H: Women and men have similar amounts of liver and intra−abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004, 47, 1360–1369.
  18. Moschos S, Chan J L, Mantzoros CS: Leptin and reproduction: a review. Fertil Steril 2002, 77, 433–444.
  19. Caprio S, Tamborlane WV, Silver D, Robinson C, Leibel R, McCarthy S, Grozman A, Belous A, Maggs D, Sherwin RS: Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol 1996, 271, 626–630.
  20. Minocci A, Savia G, Lucantoni R, Berselli ME, Tagliaferri M, Calo G, Petroni ML, de Medici C, Viberti GC, Liuzzi A: Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord 2000, 24, 1139–1144.
  21. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE: The concurrent accumulation of intra−abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002, 51, 1005–1015.
  22. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG, Hauner H: Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 1996, 28, 690–693.
  23. Montague CT, Prins JB, Sanders L, Digby JE, O’Rahilly S: Depotand sex−specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997, 46, 342–347.
  24. Schoof E, Stuppy A, Harig F, Carbon R, Horbach T, Stohr W, Rascher W, Dotsch J: Comparison of leptin gene expression in different adipose tissues in children and adults. Eur J Endocrinol 2004, 150, 579–584.
  25. Fajardo ME, Malacara JM, Martinez−Rodriguez HG, Barrera−Saldana HA: Hormone and metabolic factors associated with leptin mRNA expression in preand postmenopausal women. Steroids 2004, 69, 425–430.
  26. Garaulet M, Perez−Llamas F, Baraza JC, Garcia−Prieto MD, Fardy PS, Tebar FJ, Zamora S: Body fat distribution in pre−and postmenopausal women: metabolic and anthropometric variables. J Nutr Health Aging 2002, 6, 123–126.
  27. Ozbey N, Sencer E, Molvalilar S, Orhan Y: Body fat distribution and cardiovascular disease risk factors in preand postmenopausal obese women with similar BMI. Endocr J 2002, 49, 503–509.
  28. Kanaley JA, Sames C, Swisher L, Swick AG, Ploutz−Snyder LL, Steppan CM, Sagendorf KS, Feiglin D, Jaynes EB, Meyer RA, Weinstock RS: Abdominal fat distribution in pre−and postmenopausal women: The impact of physical activity, age, and menopausal status. Metabolism 2001, 50, 976–782.
  29. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, Newman AB: Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005, 165, 777–783.
  30. You T, Ryan AS, Nicklas BJ: The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004, 89, 5517–5522.
  31. Park HS, Lee K: Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med 2005, 22, 266–272.
  32. Von Eyben FE, Mouritsen E, Holm J, Montvilas P, Dimcevski G, Suciu G, Helleberg I, Kristensen L, von Eyben R: Intra−abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord 2003, 27, 941–949.
  33. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V: Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord 2004, 28, 1018–1025.
  34. Nicklas BJ, Penninx BW, Ryan AS, Berman DM, Lynch NA, Dennis KE: Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care 2003, 26, 1413–1420.
  35. Ruhl CE, Everhart JE: Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr 2001, 74, 295–301.
  36. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT: The metabolic significance of leptin in humans: gender−based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997, 82, 1293–1300.
  37. Lyoussi B, Ragala MA, Mguil M, Chraibi A, Israili ZH: Gender−specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans. Clin Exp Hypertens 2005, 27, 377–394.
  38. Haffner SM, Gingerich RL, Miettinen H, Stern MP: Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes Relat Metab Disord 1996, 20, 904–908.
  39. Hu FB, Chen C, Wang B, Stampfer MJ, Xu X: Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Int J Obes Relat Metab Disord 2001, 25, 121–125.
  40. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, Schick F, Haring HU, Stumvoll M: Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003, 11, 368–372.
  41. Martinez−Carpio PA, Fiol C, Hurtado I, Arias C, Ruiz E, Orozco P, Corominas A: Relation between leptin and body fat distribution in menopausal status. J Physiol Biochem 2003, 59, 301–307.
  42. Douchi T, Iwamoto I, Yoshimitsu N, Kosha S, Nagata Y: Leptin production in preand postmenopausal women. Maturitas 2002, 42, 219–223.
  43. Hadji P, Hars O, Bock K, Sturm G, Bauer T, Emons G, Schulz KD: The influence of menopause and body mass index on serum leptin concentrations. Eur J Endocrinol 2000, 143, 55–60.
  44. Tufano A, Marzo P, Enrini R, Morricone L, Caviezel F, Ambrosi B: Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. J Endocrinol Invest 2004, 27, 648–653.
  45. Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, Paizis IA, Hatzizacharias AN, Perrea D, Votteas VV: Human soluble leptin receptor number in healthy normotensive individuals with high normal blood pressure. Am J Hypertens 2005, 18, 1001–1004.
  46. Canatan H, Bakan I, Akbulut M, Baydas G, Halifeoglu I, Gursu MF: Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects. Endocrinol Res 2004, 30, 95–105.
  47. Schutte R, Huisman HW, Schutte AE, Malan NT: Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity: the POWIRS study. J Hum Hypertens 2005, 19, 535–541.
  48. Mallamaci F, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tripepi R, Zoccali C: Gender−dependent differences in plasma leptin in essential hypertension. Am J Hypertens 2000, 13, 914–920.
  49. Ren J: Leptin and hyperleptinemia – from friend to foe for cardiovascular function. J Endocrinol 2004, 181, 1–10.
© Wroclaw Medical University